Paper445964
Kinetics of intravenous melphalan.
Alberts DS and 7 others. Clin Pharmacol Ther, 1979. Cited by 111 papers, by iCite.
Cite this record
ConductScience Library. Kinetics of intravenous melphalan. Papers, record 445964. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/445964
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Melphalan | Major topic |
| Adult | |
| Aged | |
| Blood Proteins | |
| Female | |
| Half-Life | |
| Humans | |
| Hydroxylation | |
| In Vitro Techniques | |
| Injections, Intravenous | |
| Kinetics | |
| Male | |
| Metabolic Clearance Rate | |
| Middle Aged | |
| Protein Binding |
Source PubMed
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 111 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36581339 | Evaluating the Impacts of CYP3A4*1B and CYP3A5*3 Variations on Pharmacokinetic Behavior and Clinical Outcomes in Multiple Myeloma Patients With Autologous Stem Cell Transplant. | Cancer Genomics Proteomics | 2023 | https://conductscience.org/library/papers/36581339 | PubMed |
| 36537564 | Clinical Impact of Melphalan Pharmacokinetics on Transplantation Outcomes in Children Undergoing Hematopoietic Stem Cell Transplantation. | Cell Transplant | 2022 | https://conductscience.org/library/papers/36537564 | PubMed |
| 34859337 | Population Pharmacokinetics of Melphalan in a Large Cohort of Autologous and Allogeneic Hematopoietic Cell Transplantation Recipients: Towards Individualized Dosing Regimens. | Clin Pharmacokinet | 2022 | https://conductscience.org/library/papers/34859337 | PubMed |
| 32848191 | Melphalan pharmacokinetics and transplant related toxicity during autologous stem cell transplantation. | Bone Marrow Transplant | 2021 | https://conductscience.org/library/papers/32848191 | PubMed |
| 31428821 | Pharmacokinetics of thiotepa in high-dose regimens for autologous hematopoietic stem cell transplant in Japanese patients with pediatric tumors or adult lymphoma. | Cancer Chemother Pharmacol | 2019 | https://conductscience.org/library/papers/31428821 | PubMed |
| 30631618 | Sinusoidal Obstruction Syndrome (SOS) in Multiple Myeloma with Renal Failure. | Case Rep Oncol Med | 2018 | https://conductscience.org/library/papers/30631618 | PubMed |
| 30261554 | Population pharmacokinetics of carboplatin, etoposide and melphalan in children: a re-evaluation of paediatric dosing formulas for carboplatin in patients with normal or mild impairment of renal function. | Br J Clin Pharmacol | 2019 | https://conductscience.org/library/papers/30261554 | PubMed |
| 16430310 | Mass balance studies, with a focus on anticancer drugs. | Clin Pharmacokinet | 2006 | https://conductscience.org/library/papers/16430310 | PubMed |
| 15752378 | Melphalan pharmacokinetics in children with malignant disease: influence of body weight, renal function, carboplatin therapy and total body irradiation. | Br J Clin Pharmacol | 2005 | https://conductscience.org/library/papers/15752378 | PubMed |
| 15656694 | Interactions between antiretrovirals and antineoplastic drug therapy. | Clin Pharmacokinet | 2005 | https://conductscience.org/library/papers/15656694 | PubMed |
| 8462127 | Glutathione depletion increases the cytotoxicity of melphalan to PC-3, an androgen-insensitive prostate cancer cell line. | Cancer Chemother Pharmacol | 1993 | https://conductscience.org/library/papers/8462127 | PubMed |
| 7679331 | Phase II trial and pharmacokinetic assessment of intravenous melphalan in patients with advanced prostate cancer. | Cancer Chemother Pharmacol | 1993 | https://conductscience.org/library/papers/7679331 | PubMed |
| 7318146 | Pharmacologic studies of anticancer drugs with the human tumor stem cell assay. | Cancer Chemother Pharmacol | 1981 | https://conductscience.org/library/papers/7318146 | PubMed |
| 7296753 | Melphalan estimation by quantitative thin-layer chromatography. Observations on melphalan hydrolysis in vitro and pharmacokinetics in rabbits. | Cancer Chemother Pharmacol | 1981 | https://conductscience.org/library/papers/7296753 | PubMed |
| 7139852 | Plasma melphalan and prednisolone concentrations during oral therapy for multiple myeloma. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/7139852 | PubMed |
| 6861266 | Pharmacokinetics of melphalan in children following high-dose intravenous injection. | Cancer Chemother Pharmacol | 1983 | https://conductscience.org/library/papers/6861266 | PubMed |
| 6840181 | The pharmacokinetics of melphalan in patients with multiple myeloma: an intravenous/oral study using a conventional dose regimen. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6840181 | PubMed |
| 6705135 | Comparison of the fed and fasting states on the absorption of melphalan in multiple myeloma. | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6705135 | PubMed |
| 6678879 | Pharmacokinetics of high dose melphalan. | Invest New Drugs | 1983 | https://conductscience.org/library/papers/6678879 | PubMed |
| 4053266 | In vitro evaluation of anticancer drugs in relation to development of drug resistance in the human tumor clonogenic assay. | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/4053266 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/445964
GET https://conductscience.org/api/papers/v1/445964/cited_by?page=2